551 related articles for article (PubMed ID: 36741002)
1. Purinergic signaling: Diverse effects and therapeutic potential in cancer.
Kaur J; Dora S
Front Oncol; 2023; 13():1058371. PubMed ID: 36741002
[TBL] [Abstract][Full Text] [Related]
2. Purine and purinergic receptors.
Burnstock G
Brain Neurosci Adv; 2018; 2():2398212818817494. PubMed ID: 32166165
[TBL] [Abstract][Full Text] [Related]
3. Extracellular nucleotide signaling in the inner ear.
Housley GD
Mol Neurobiol; 1998 Feb; 16(1):21-48. PubMed ID: 9554700
[TBL] [Abstract][Full Text] [Related]
4. Purinergic Signaling and its Role in the Stem Cell Differentiation.
Zaib S; Areeba ; Khan I
Mini Rev Med Chem; 2024; 24(8):863-883. PubMed ID: 37828668
[TBL] [Abstract][Full Text] [Related]
5. Purinoceptors: are there families of P2X and P2Y purinoceptors?
Abbracchio MP; Burnstock G
Pharmacol Ther; 1994; 64(3):445-75. PubMed ID: 7724657
[TBL] [Abstract][Full Text] [Related]
6. Neuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X₁, P2X₂, P2X₃ channels, P2Y and A₃ metabotropic receptors in neurotransmission.
Liñán-Rico A; Wunderlich JE; Enneking JT; Tso DR; Grants I; Williams KC; Otey A; Michel K; Schemann M; Needleman B; Harzman A; Christofi FL
Neuropharmacology; 2015 Aug; 95():83-99. PubMed ID: 25724083
[TBL] [Abstract][Full Text] [Related]
7. P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.
Woods LT; Forti KM; Shanbhag VC; Camden JM; Weisman GA
Biochem Pharmacol; 2021 May; 187():114406. PubMed ID: 33412103
[TBL] [Abstract][Full Text] [Related]
8. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
[TBL] [Abstract][Full Text] [Related]
9. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
Yu Y; Zhang C
Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
[TBL] [Abstract][Full Text] [Related]
10. Purinergic signaling in B cells.
Przybyła T; Sakowicz-Burkiewicz M; Pawełczyk T
Acta Biochim Pol; 2018; 65(1):1-7. PubMed ID: 29360885
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
12. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
13. Purine and pyrimidine receptors.
Burnstock G
Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
[TBL] [Abstract][Full Text] [Related]
14. Purinergic signalling: pathophysiology and therapeutic potential.
Burnstock G
Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
[TBL] [Abstract][Full Text] [Related]
15. Purinergic transmission in blood vessels.
Ralevic V; Dunn WR
Auton Neurosci; 2015 Sep; 191():48-66. PubMed ID: 26004513
[TBL] [Abstract][Full Text] [Related]
16. Agonists and Antagonists for Purinergic Receptors.
Müller CE; Baqi Y; Namasivayam V
Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
[TBL] [Abstract][Full Text] [Related]
17. P2-type purinergic signaling in the regulation of pancreatic β-cell functional plasticity as a promising novel therapeutic approach for the treatment of type 2 diabetes?
Mesto N; Movassat J; Tourrel-Cuzin C
Front Endocrinol (Lausanne); 2022; 13():1099152. PubMed ID: 37065173
[TBL] [Abstract][Full Text] [Related]
18. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
Burnstock G
Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
[TBL] [Abstract][Full Text] [Related]
19. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
20. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Washburn KB; Neary JT
Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]